Related Experiment Video
Updated: Aug 6, 2026

Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
Renal dysfunction increases the risk of saphenous vein graft occlusion: results from the Post-CABG trial
Gregory A Wellenius1, Kenneth J Mukamal, Wolfgang C Winkelmayer
1Cardiovascular Epidemiology Research Unit, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Deaconess 306, Boston, MA 02215, USA. gwelleni@bidmc.harvard.edu
Insights
Chronic kidney disease (CKD) may increase the risk of saphenous vein graft occlusion after coronary artery bypass graft (CABG) surgery. This risk appears related to plaque disruption, not atherosclerotic progression.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Vascular Surgery
Background:
- Saphenous vein grafts are frequently used in coronary artery bypass grafting (CABG).
- Chronic kidney disease (CKD) is a known cardiovascular risk factor.
- The impact of CKD on saphenous vein graft disease is not well understood.
Purpose of the Study:
- To evaluate the association between chronic kidney disease (CKD) and the progression of disease in saphenous vein grafts post-coronary artery bypass graft (CABG) surgery.
- To investigate whether CKD influences graft occlusion, lumen diameter changes, or clinical events.
Main Methods:
- Analysis of data from the Post-CABG Trial involving 1351 patients undergoing CABG surgery.
- Patients were stratified by baseline estimated glomerular filtration rate (eGFR).
- Coronary angiography assessed graft disease progression, occlusion, lumen diameter, and clinical events over a median follow-up of 4.2 years.
Main Results:
- A decreasing eGFR was significantly associated with an increased risk of graft occlusion (P(trend)=0.040).
- No significant association was found between decreasing eGFR and atherosclerotic progression (P(trend)=0.30), lumen diameter changes (P(trend)=0.067), or recurrent clinical events (P(trend)=0.86).
- CKD did not significantly modify treatment effects.
Conclusions:
- Chronic kidney disease (CKD) may be linked to a higher risk of atherosclerotic plaque disruption in saphenous vein grafts.
- The findings suggest CKD's role in graft disease may involve instability rather than gradual narrowing.
Objectives:
Saphenous vein grafts are common among patients with a history of coronary artery bypass graft (CABG) surgery. Chronic kidney disease (CKD) is an established cardiovascular risk factor, but its role in graft disease has not been evaluated.
Methods And Results:
The Post-CABG Trial randomized 1351 patients who had undergone CABG surgery 1-11 years earlier to high- or low-dose lovastatin and to low-dose warfarin or placebo. Coronary angiography was conducted at baseline and after a median follow-up time of 4.2 years. Subjects were grouped according to their baseline estimated glomerular filtration rate (eGFR). The primary trial endpoint was significant graft disease progression assessed angiographically. Additional pre-defined endpoints included occlusion of grafts patent at baseline, change in minimum lumen diameter, and a composite endpoint of recurrent clinical events. Decreasing eGFR was associated with an increased risk of graft occlusion (P(trend)=0.040), but not substantial atherosclerotic progression (P(trend)=0.30), per-graft change in minimum lumen diameter (P(trend)=0.067), or recurrent clinical events (P(trend)=0.86). We did not observe significant effect modification of treatment effects by the presence of CKD.
Conclusions:
CKD may be associated with increased risk of atherosclerotic plaque disruption rather than atherosclerotic progression in saphenous vein grafts.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Hemodialysis I: Introduction
Aneurysm III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose Veins I: Introduction

